Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro

Molecular Medicine Reports

Volumn 1, Issue 4, 2008, Pages 537-542

  Fukahori, Suguru ^a,b   Yano, Hirohisa ^a,b   Akiba, Jun ^a,b   Ogasawara, Sachiko ^a,b   Momosaki, Seiya ^a,b   Sanada, Sakiko ^a,b   Kuratomi, Keitaro ^a,b   Ishizaki, Yasuhiro ^a,b   Moriya, Fukuko ^a,b   Yagi, Minoru ^a,b   Kojiro, Masamichi ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Anti tumor; Apoptosis; Cell cycle; Fucoidan

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FUCOIDIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL ASSAY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; GALLBLADDER CANCER; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CANCER; LIVER CELL CARCINOMA; NEUROBLASTOMA; NONHUMAN; OVARY CANCER; SEAWEED;

EID: 69249159493     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.4.537     Document Type: Article

References (30)

1. Nakachi K, Matsuyama S, Miyake S, Suganuma M and Imai K: Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13: 49-54, 2000. (Pubitemid 32107344)
2. Parish CR, Coombe DR, Jakobsen KB, Bennett FA and Underwood PA: Evidence that sulfated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases. Int J Cancer 40: 511-518, 1987.
3. Zhuang C, Itoh H, Mizuno T and Ito H: Antitumor active fucoidan from the brown seaweed, umitoranoo (Sargassum thunbergii). Biosci Biotechnol Biochem 59: 563-567, 1995.
4. Riou D, Colliec-Jouault S, Pinczon du Sel D, et al: Antitumor and antiproliferative effects of a fucan extracted from ascophyllum nodosum against a non-small-cell broncho-pulmonary carcinoma line. Anticancer Res 16: 1213-1218, 1996.
5. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S and Shimeno H: Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65: 173-179, 2003. (Pubitemid 36015820)
6. Maruyama H, Tamauchi H, Hashimoto M and Nakano T: Antitumor activity and immune response of Mekabu fucoidan extracted from Sporophyll of Undaria pinnatifida. In Vivo 17: 245-249, 2003. (Pubitemid 36958113)
7. Colliec S, Fischer AM, Tapon-Bretaudiere J, Boisson C, Durand P and Jozefonvicz J: Anticoagulant properties of a fucoidan fraction. Thromb Res 64: 143-154, 1991.
8. Trento F, Cattaneo F, Pescador R, Porta R and Ferro L: Antithrombin activity of an algal polysaccharide. Thromb Res 102: 457-465, 2001.
9. Durig J, Bruhn T, Zurborn KH, Gutensohn K, Bruhn HD, and Beress L: Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro. Thromb Res 85: 479-491, 1997. (Pubitemid 27209939)
10. Baba M, Schols D, Pauwels R, Nakashima H and De Clercq E: Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J Acquir Immune Defic Syndr 3: 493-499, 1990. (Pubitemid 20251504)
11. McClure MO, Moore JP, Blanc DF, et al: Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses 8: 19-26, 1992.
12. Nagaoka M, Shibata H, Kimura-Takagi I, et al: Structural study of fucoidan from Cladosiphon okamuranus tokida. Glycoconj J 16: 19-26, 1999. (Pubitemid 29363028)
13. Sakai T, Ishizuka K, Shimanaka K, Ikai K and Kato I: Structures of oligosaccharides derived from Cladosiphon okamuranus fucoidan by digestion with marine bacterial enzymes. Mar Biotechnol 5: 536-544, 2003.
14. Murakami T: Establishment and characterization of a new human hepatocellular carcinoma cell line (KIM-1). Acta Hepatol Jpn 25: 532-539, 1988.
15. Yano H, Kojiro M and Nakashima T: A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma. In Vitro Cell Dev Biol 22: 637-646, 1986. (Pubitemid 17022420)
16. Yano H, Maruiwa M, Murakami T, et al: A new human pleomorphic hepatocellular carcinoma cell line, KYN-2. Acta Pathol Jpn 38: 953-966, 1988. (Pubitemid 18224057)
17. Murakami T, Maruiwa M, Fukuda K, Kojiro M, Tanaka M and Tanikawa K: Characterization of a new human hepatoma cell line (KYN-3) derived from the ascites of the hepatoma patient [abstract]. Jpn J Cancer Res Proceedings of the Japanese Cancer Association 192, 1988.
18. Yano H, Iemura A, Fukuda K, Mizoguchi A, Haramaki M and Kojiro M: Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells. Hepatology 18: 320-327, 1993. (Pubitemid 23225103)
19. Iemura A, Maruiwa M, Yano H and Kojiro M: A new human cholangiocellular carcinoma cell line (KMC-1). J Hepatol 15: 288-298, 1992.
20. Tomioka Y: Establishment and characterization of three human ovarian clear cell carcinoma cell line. J Kurume Med Assoc 61: 323-333, 1998.
21. Takemoto Y, Yano H, Momosaki S, et al: Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo. Clin Cancer Res 10: 7418-7426, 2004. (Pubitemid 39487731)
22. Inoue M, Yano H and Kojiro M: Expression of Fas and antimediated apoptosis in human renal cell carcinoma. Int J Oncol 9: 49-56, 1996. (Pubitemid 26201894)
23. Yano H, Iemura A, Haramaki M, et al: Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology 29: 1708-1717, 1999. (Pubitemid 29247043)
24. Haneji K, Matsuda T, Tomita M, et al: Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. Nutr Cancer 52: 189-201, 2005. (Pubitemid 41579761)
25. Aisa Y, Miyakawa Y, Nakazato T, et al: Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol 78: 7-14, 2005. (Pubitemid 40023740)
26. Itoh H, Noda H, Amano H and Ito H: Immunological analysis of inhibition of lung metastases by fucoidan (GIV-A) prepared from brown seaweed Sargassum thunbergii. Anticancer Res 15: 1937-1947, 1995.
27. Coombe DR, Parish CR, Ramshaw IA and Snowden JM: Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer 39: 82-88, 1987.
28. Liu JM, Haroun-Bouhedja F and Boisson-Vidal C: Analysis of the in vitro inhibition of mammary adenocarcinoma cell adhesion by sulphated polysaccharides. Anticancer Res 20: 3265-3271, 2000. (Pubitemid 30802708)
29. Yamamoto I, Takahashi M, Suzuki T, Seino H and Mori H: Antitumor effect of seaweeds. IV. Enhancement of antitumor activity by sulfation of a crude fucoidan fraction from Sargassum kjellmanianum. Jpn J Exp Med 54: 143-151, 1984. (Pubitemid 14010593)
30. Ellouali M, Boisson-Vidal C, Durand P and Jozefonvicz J: Antitumor activity of low molecular weight fucans extracted from brown seaweed Ascophyllum nodosum. Anticancer Res 13: 2011-2019, 1993. (Pubitemid 24036319)